New cancer therapies target epigenetic switch

Cancers emerge from many different paths. One path begins early, in embryonic development, when a protein complex called PRC2, which regulates cell differentiation, identity, and plasticity, becomes dysfunctional. PRC2 has well-established links to breast, prostate, blood, and...

🔗 Read more: https://medicalxpress.com/news/2026-03-cancer-therapies-epigenetic.html

#News #Biology #Genetics #Medicine #Science